Aim
The aim of the present study was to screen for compounds with cytotoxic activity in oral cancer cells and characterize the observed effect.
Methods
Constituents of LCC were extracted, purified and subjected to chemical reactions to generate new compounds. Oral squamous carcinoma cells (OSCC-3) were treated with the parental and derived compounds (total of 8) at 25ng/uL for 24h, 48h and 72h, as well as with staurosporine (300nM) and ethanol (diluent of compounds); as positive and negative controls, respectively. Citotoxicity and cell viability were measured by spectrophotometry and crystal violet assays. To investigate dose-dependency, treatment with compounds with promising results was additionally carried out, at concentrations of 0, 5, 10, and 25ng/mL, and cell viability was measured. In order to identify the type of cell death, DNA fragmentation studies and Western Blot for caspases were performed.
Results
Of the eight compounds tested, four showed initial cytotoxic activity at 25ng/mL, at all incubation times analyzed. When tested for dose-dependency, two compounds induced, at concentrations between 10 and 25ng/mL, a marked decrease in cell viability, which dropped from approximately 70% to less than 20%. DNA fragmentation assay showed that one compound induced apoptosis, whereas its saturated counterpart did not. These results were further expanded by western blot analyses.
Conclusion
Compounds derived from LCC have considerable cytotoxic activity towards oral cancer cells. Because of their versatility, it is possible to determine molecular motifs that may mediate these effects. In this light, new therapeutic agents may be developed from the compounds tested.
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